Alumni Spotlight: Mandar Kulkarni PhD

Several times a year, we attempt to spotlight one of our alumni. Today, we spotlight Mandar KLulkarni. 

After obtaining his doctoral degree in molecular carcinogenesis from Purdue University, Mandar was selected as a T32 trainee and joined Dr. Michael Hodsdon's lab at the Yale school of Medicine. His work focused on elucidating the mechanism of pH-dependence of the human prolactin:prolactin receptor interaction, with the intent of abrogating such pH-dependence so that breast cancer cells may become refractory to prolactin mediated unregulated cancerous growth. He was awarded the young investigator award by the ACLPS for his work at Yale. After his fellowship, he worked as a senior scientist at M/Z Diagnostics, where he developed a rapid clinical assay for antibiotic resistance, managed business activity, obtained an NIH-SBIR grant as a PI, and was awarded a young investigator award by the FSG. He then chose to return to his roots in India and has been appointed as the Chief Technology Office at Cancer Genetics India, where he is responsible for ensuring the financial success of the Indian business unit while focusing on developing and clinically validating genomics-based clinical assay in the area of precision oncology. He has established several high value collaborations to transform the Indian personalized oncology diagnostics landscape.  

Quote: “I believe that the mentor-ship received from Dr. Hodsdon and Dr. Smith at Yale is at the heart of my scientific creativity and has been the most liberating, inspiring, and transformative experiences that will continue to support my success.”

Alumnus Mohiedean Ghofrani, MD, MBA appointed as Trustee for the American Board of Pathology


January 10, 2017

The American Board of Pathology (ABP), Tampa, FL, is pleased to announce the election of two new Trustees for terms beginning in 2017:

Mohiedean Ghofrani, M.D., M.B.A.

Dr. Ghofrani is Director of Cytopathology and Women’s Health at PeaceHealth Laboratories in Vancouver, WA. He earned his medical degree in Tehran, followed by residency in Anatomic and Clinical Pathology and Fellowship in Cytopathology at Yale University. Dr. Ghofrani has subspecialty training and expertise in breast and gynecologic pathology. He holds a Master of Business Administration with focus on healthcare from George Washington University, and has a special interest in clinical informatics. Dr. Ghofrani is active in state, national and international pathology societies, and has served as President of the Washington State Society of Pathologists, President of the Oregon Pathologists Association, Chair of the American Society of Cytopathology Budget and Finance Committee, and Vice-Chair of the College of American Pathologists Cytopathology Committee. He is board certified in Anatomic and Clinical Pathology, Cytopathology, and Clinical Informatics and is participating in the Maintenance of Certification program.

Alumna Li Chai awarded major Myelodysplasia Grant

Li Chai, MD, former Yale Transfusion Medicine Fellow and now Associate medical director of Adult Transfusion Medicine at the Department of Pathology at BWH and Assistant professor of Pathology at Harvard, was recently honored with the 2013 V Foundation MDS Grant. The MDS Grant was established in honor of Good Morning America co-host Robin Roberts, and is awarded to support those dedicated to finding a cure for myelodysplastic syndromes (MDS).

A blood banker and associate pathologist at BWH, Chai is being recognized for her research in targeting leukemic stem cell factors in MDS and acute myeloid leukemia (AML). She is one of two MDS grant recipients this year and will receive $600,000 over three years to fund her research.

The V Foundation for Cancer Research was formed by ESPN commentator and legendary basketball coach Jim Valvano. Since being established in 1993, the V Foundation has awarded more than $115 million in cancer research grants nationwide and awards 100 percent of all direct cash donations to cancer research and related programs. The foundation is guided by an elite, all-volunteer Scientific Advisory Board, which recommends the research projects funded. This board is comprised of top physicians and research scientists from prominent universities and cancer centers nationwide.

Nancy Young elected President of the American Society of Cytopathology

Nancy A. Young, MD is currently President-elect of the American Society of Cytopathology, with her term as President to begin in November, 2010. Dr Young is also Chair of Pathology and Laboratory Medicine at Albert Einstein Medical Center in Philadelphia and Professor of Pathology, Anatomy, and Cell Biology at Thomas Jefferson Medical College in Philadelphia.

Alumna Kimberle Chapin appointed Chair of the American Board of Medical Microbiology

Kimberle Chapin, MD, a former resident and medical microbiology fellow in our Department, was appointed Chair of the American Board of Medical Microbiology. The American College of Microbiology oversees all certification and accreditation activities of the American Society of Microbiology. Dr. Chapin is Director, Microbiology Laboratory, Lifespan Academic Medical Centers and Associate Professor of Pathology and Medicine at Brown.

Symposiums, Clubs and Conferences

Full schedule of conferences and symposiums and online calendar.

Residency Lectures & Conferences

Morning report, clinical case conference, journal club, research seminars, etc.

Laboratory Medicine Newsletter

Topics in clinical laboratory medicine.

Clinical Virology Newsletter

The clinical virology newsletter is distributed two to four times a year.